Data:
{
"symbol": "INCY",
"price": 113.02,
"marketCap": 22908898572,
"beta": 0.739,
"lastDividend": 0,
"range": "84.02-132.6",
"change": -0.05000336,
"changePercentage": -0.04422336,
"volume": 277268,
"averageVolume": 1742485,
"companyName": "Incyte Corporation",
"currency": "USD",
"cik": "0000879169",
"isin": "US45337C1027",
"cusip": "45337C102",
"exchangeFullName": "NASDAQ Global Select",
"exchange": "NASDAQ",
"industry": "Biotechnology",
"website": "https://www.incyte.com",
"description": "Incyte Corporation is a biopharmaceutical firm engaged in the research, development, and global marketing of its own innovative therapies. Its current product offerings include JAKAFI, prescribed for myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that targets oncogenic drivers in various liquid and solid tumor types; and ICLUSIG, a kinase inhibitor utilized for chronic myeloid leukemia and Philadelphia-chromosome positive acute lymphoblastic leukemia. Beyond its marketed drugs, Incyte's pipeline features several promising candidates. Among its clinical-stage assets are ruxolitinib, targeting steroid-refractory chronic graft-versus-host disease (GVHD), and itacitinib, which is undergoing Phase II/III trials for newly diagnosed chronic GVHD. Pemigatinib is also being investigated for conditions such as bladder cancer, cholangiocarcinoma, myeloproliferative syndrome, and other tumor types. Further advancing its research, the company is developing Parsaclisib, currently in Phase II studies for follicular lymphoma, marginal zone lymphoma, and mantle cell lymphoma. Additionally, Retifanlimab is in Phase II development for multiple indications, including MSI-high endometrial cancer, Merkel cell carcinoma, anal cancer, and non-small cell lung cancer. Incyte maintains a broad network of strategic alliances with numerous pharmaceutical and biotech companies, including key partners like Novartis International Pharmaceutical Ltd., Eli Lilly and Company, and Agenus Inc., among many others. These collaborations extend to clinical trials, notably joint efforts with MorphoSys AG and Xencor, Inc., to evaluate a combination therapy involving tafasitamab, plamotamab, and lenalidomide for patients with recurrent or resistant diffuse large B-cell lymphoma and follicular lymphoma. Established in 1991, the corporation's main offices are situated in Wilmington, Delaware.",
"ceo": "William J. Meury",
"sector": "Healthcare",
"country": "US",
"fullTimeEmployees": "2844",
"phone": "302 498 6700",
"address": "1801 Augustine Cut-Off",
"city": "Wilmington",
"state": "DE",
"zip": "19803",
"image": "https://images.financialmodelingprep.com/symbol/INCY.png",
"ipoDate": "1993-11-04",
"defaultImage": false,
"isEtf": false,
"isActivelyTrading": true,
"isAdr": false,
"isFund": false
}
Data:
{
"symbol": "INCY",
"name": "Incyte Corporation",
"price": 113.0406,
"changePercentage": -0.02600159,
"change": -0.0294,
"volume": 333151.69551,
"dayLow": 112.71,
"dayHigh": 114.38,
"yearHigh": 132.6,
"yearLow": 84.02,
"marketCap": 22913074826,
"priceAvg50": 121.834,
"priceAvg200": 107.49905,
"exchange": "NASDAQ",
"open": 113.19,
"previousClose": 113.07,
"timestamp": 1792427220,
"quote_spread": {},
"chart_vwap_daily": [
{
"t": "2026-09-08",
"v": 124.8719,
"c": 124.4
},
{
"t": "2026-09-09",
"v": 126.153,
"c": 126.01
},
{
"t": "2026-09-10",
"v": 123.8615,
"c": 123.28
},
{
"t": "2026-09-11",
"v": 122.0571,
"c": 121.47
},
{
"t": "2026-09-14",
"v": 122.3139,
"c": 122.19
},
{
"t": "2026-09-15",
"v": 121.3365,
"c": 121.74
},
{
"t": "2026-09-16",
"v": 124.2042,
"c": 124.75
},
{
"t": "2026-09-17",
"v": 126.9772,
"c": 127.62
},
{
"t": "2026-09-18",
"v": 125.8436,
"c": 125.31
},
{
"t": "2026-09-21",
"v": 125.3316,
"c": 124.65
},
{
"t": "2026-09-22",
"v": 126.6862,
"c": 126.93
},
{
"t": "2026-09-23",
"v": 124.989,
"c": 124.64
},
{
"t": "2026-09-24",
"v": 124.211,
"c": 124.44
},
{
"t": "2026-09-25",
"v": 124.1091,
"c": 123.89
},
{
"t": "2026-09-28",
"v": 124.5628,
"c": 124.82
},
{
"t": "2026-09-29",
"v": 123.0323,
"c": 123.2
},
{
"t": "2026-09-30",
"v": 121.9793,
"c": 121.35
},
{
"t": "2026-10-01",
"v": 118.2679,
"c": 117.14
},
{
"t": "2026-10-02",
"v": 115.4906,
"c": 115.3
},
{
"t": "2026-10-05",
"v": 113.9853,
"c": 114.13
},
{
"t": "2026-10-06",
"v": 113.1995,
"c": 112.73
},
{
"t": "2026-10-07",
"v": 113.8732,
"c": 113.44
},
{
"t": "2026-10-08",
"v": 112.2676,
"c": 112.75
},
{
"t": "2026-10-09",
"v": 112.9724,
"c": 112.79
},
{
"t": "2026-10-12",
"v": 111.9385,
"c": 111.36
},
{
"t": "2026-10-13",
"v": 108.6324,
"c": 108.62
},
{
"t": "2026-10-14",
"v": 111.3142,
"c": 111.57
},
{
"t": "2026-10-15",
"v": 113.7911,
"c": 113.27
},
{
"t": "2026-10-16",
"v": 113.1721,
"c": 113.07
},
{
"t": "2026-10-19",
"v": 113.2685,
"c": 113.07
}
],
"vwap_summary": {
"days": 30,
"days_above": 10,
"days_below": 20,
"pct_days_above": 33,
"position": "below",
"gap_pct": -0.18,
"streak_days": 3
}
}
Data:
{
"volume": 333151.69551,
"avgVolume": 1742485,
"short_ratio": [
{
"symbol": "INCY",
"file_date": "2026-10-16",
"date": "20261016",
"short_volume": 388177,
"short_exempt_volume": 0,
"total_volume": 540511,
"short_volume_ratio": 0.7182,
"signal": "Bearish"
}
],
"volume_profile": {
"poc": 113.37,
"vah": 120.82,
"val": 108.25,
"profile": [
{
"price": 108.08,
"volume": 299045
},
{
"price": 108.41,
"volume": 890978
},
{
"price": 108.74,
"volume": 403329
},
{
"price": 109.07,
"volume": 402834
},
{
"price": 109.4,
"volume": 9561
},
{
"price": 109.73,
"volume": 19792
},
{
"price": 110.07,
"volume": 110166
},
{
"price": 110.4,
"volume": 100465
},
{
"price": 110.73,
"volume": 286570
},
{
"price": 111.06,
"volume": 512140
},
{
"price": 111.39,
"volume": 840832
},
{
"price": 111.72,
"volume": 688115
},
{
"price": 112.05,
"volume": 387671
},
{
"price": 112.38,
"volume": 467980
},
{
"price": 112.71,
"volume": 1524871
},
{
"price": 113.04,
"volume": 1624657
},
{
"price": 113.37,
"volume": 1724138
},
{
"price": 113.71,
"volume": 1221088
},
{
"price": 114.04,
"volume": 1340115
},
{
"price": 114.37,
"volume": 483783
},
{
"price": 114.7,
"volume": 777814
},
{
"price": 115.03,
"volume": 555444
},
{
"price": 115.36,
"volume": 731248
},
{
"price": 115.69,
"volume": 156992
},
{
"price": 116.02,
"volume": 89917
},
{
"price": 116.35,
"volume": 147095
},
{
"price": 116.68,
"volume": 121414
},
{
"price": 117.01,
"volume": 48799
},
{
"price": 117.34,
"volume": 541550
},
{
"price": 117.68,
"volume": 119140
},
{
"price": 118.01,
"volume": 113791
},
{
"price": 118.34,
"volume": 25852
},
{
"price": 118.67,
"volume": 370954
},
{
"price": 119.0,
"volume": 166550
},
{
"price": 119.33,
"volume": 71300
},
{
"price": 119.66,
"volume": 116894
},
{
"price": 119.99,
"volume": 94088
},
{
"price": 120.32,
"volume": 178742
},
{
"price": 120.65,
"volume": 74809
},
{
"price": 120.98,
"volume": 0
},
{
"price": 121.31,
"volume": 317406
},
{
"price": 121.65,
"volume": 70504
},
{
"price": 121.98,
"volume": 137320
},
{
"price": 122.31,
"volume": 317391
},
{
"price": 122.64,
"volume": 158381
},
{
"price": 122.97,
"volume": 419713
},
{
"price": 123.3,
"volume": 811403
},
{
"price": 123.63,
"volume": 527651
},
{
"price": 123.96,
"volume": 661173
},
{
"price": 124.29,
"volume": 820024
},
{
"price": 124.62,
"volume": 747316
},
{
"price": 124.95,
"volume": 578037
},
{
"price": 125.29,
"volume": 183010
},
{
"price": 125.62,
"volume": 106169
},
{
"price": 125.95,
"volume": 169658
},
{
"price": 126.28,
"volume": 164222
},
{
"price": 126.61,
"volume": 106506
},
{
"price": 126.94,
"volume": 349367
},
{
"price": 127.27,
"volume": 159545
},
{
"price": 127.6,
"volume": 103732
}
],
"sessions": 20
}
}
Data:
{
"symbol": "INCY",
"marketCap": 22918567935,
"enterpriseValueTTM": 18974459935,
"evToSalesTTM": 3.260479787027475,
"evToOperatingCashFlowTTM": 9.584498247969519,
"evToFreeCashFlowTTM": 9.880133225477566,
"evToEBITDATTM": 9.175403867077376,
"netDebtToEBITDATTM": -1.90723656532735,
"currentRatioTTM": 4.663158031119674,
"incomeQualityTTM": 1.227811878443273,
"grahamNumberTTM": 75.71318731156207,
"grahamNetNetTTM": 19.50160821048219,
"taxBurdenTTM": 0.8195655809324461,
"interestBurdenTTM": 0.9988201171049004,
"workingCapitalTTM": 4806415000,
"investedCapitalTTM": 5777639000,
"returnOnAssetsTTM": 0.2048082430216927,
"operatingReturnOnAssetsTTM": 0.24156705075546814,
"returnOnTangibleAssetsTTM": 0.21114297728093848,
"returnOnEquityTTM": 0.29700345971970143,
"returnOnInvestedCapitalTTM": 0.245873059947206,
"returnOnCapitalEmployedTTM": 0.28005726957994836,
"earningsYieldTTM": 0.0711671567060362,
"freeCashFlowYieldTTM": 0.0837952007056762,
"capexToOperatingCashFlowTTM": 0.029922165092440632,
"capexToDepreciationTTM": 0.6027186797309809,
"capexToRevenueTTM": 0.010179000709679304,
"salesGeneralAndAdministrativeToRevenueTTM": 0.24045498519639902,
"researchAndDevelopementToRevenueTTM": 0.36958465718021905,
"stockBasedCompensationToRevenueTTM": 0.03228456593573708,
"intangiblesToTotalAssetsTTM": 0.030002107296313425,
"averageReceivablesTTM": 1088351000,
"averagePayablesTTM": 239512500,
"averageInventoryTTM": 114083000,
"daysOfSalesOutstandingTTM": 70.57255396913497,
"daysOfPayablesOutstandingTTM": 212.76888748175446,
"daysOfInventoryOutstandingTTM": 95.62835665581052,
"operatingCycleTTM": 166.2009106249455,
"cashConversionCycleTTM": -46.56797685680897,
"freeCashFlowToEquityTTM": 1885825000,
"freeCashFlowToFirmTTM": 1892370670.410087,
"tangibleAssetValueTTM": 6108231000,
"netCurrentAssetValueTTM": 4590291000,
"grossProfitMarginTTM": 0.9261869944823723,
"ebitMarginTTM": 0.33846152524344747,
"ebitdaMarginTTM": 0.35535000249161014,
"operatingProfitMarginTTM": 0.3157179359845211,
"pretaxProfitMarginTTM": 0.33806218027916346,
"continuousOperationsProfitMarginTTM": 0.2770641271717819,
"netProfitMarginTTM": 0.2770641271717819,
"bottomLineProfitMarginTTM": 0.2770641271717819,
"receivablesTurnoverTTM": 5.171982300082741,
"payablesTurnoverTTM": 1.7154763758930676,
"inventoryTurnoverTTM": 3.8168594835705782,
"fixedAssetTurnoverTTM": 7.9174262749174185,
"assetTurnoverTTM": 0.7392088074062002,
"quickRatioTTM": 4.577385343755335,
"solvencyRatioTTM": 1.1193846435722605,
"cashRatioTTM": 3.0351247164841597,
"priceToEarningsRatioTTM": 13.907466174661748,
"priceToEarningsGrowthRatioTTM": 0.17240660547101327,
"forwardPriceToEarningsGrowthRatioTTM": -0.2657504223842418,
"priceToEarningsDilutedRatioTTM": 14.403528662420383,
"priceToEarningsDilutedGrowthRatioTTM": 0.1836971771439122,
"priceToBookRatioTTM": 3.5710521360873093,
"priceToSalesRatioTTM": 3.938216305268639,
"priceToFreeCashFlowRatioTTM": 11.933857686103268,
"priceToOperatingCashFlowRatioTTM": 11.444282092111797,
"debtToAssetsRatioTTM": 0.004860753949719834,
"debtToEquityRatioTTM": 0.006031592766375908,
"debtToCapitalRatioTTM": 0.005995430769515192,
"longTermDebtToCapitalRatioTTM": 0,
"financialLeverageRatioTTM": 1.2408759687833117,
"workingCapitalTurnoverRatioTTM": 1.322466267001143,
"operatingCashFlowRatioTTM": 1.5088095688120382,
"operatingCashFlowSalesRatioTTM": 0.34018262643203145,
"freeCashFlowOperatingCashFlowRatioTTM": 0.9700778349075594,
"debtServiceCoverageRatioTTM": 737.0869191049914,
"interestCoverageRatioTTM": 790.5895008605852,
"shortTermOperatingCashFlowCoverageRatioTTM": 0,
"operatingCashFlowCoverageRatioTTM": 51.73394831055479,
"capitalExpenditureCoverageRatioTTM": 33.42004152809899,
"dividendPaidAndCapexCoverageRatioTTM": 33.42004152809899,
"dividendPayoutRatioTTM": 0,
"dividendYieldTTM": 0,
"revenuePerShareTTM": 29.042759185140085,
"netIncomePerShareTTM": 8.04670672429109,
"interestDebtPerShareTTM": 0.2025721386579365,
"cashPerShareTTM": 22.635918114763097,
"bookValuePerShareTTM": 31.662293265727776,
"tangibleBookValuePerShareTTM": 30.48354110730719,
"shareholdersEquityPerShareTTM": 31.662293265727776,
"operatingCashFlowPerShareTTM": 9.87984209843396,
"capexPerShareTTM": 0.29562626635658606,
"freeCashFlowPerShareTTM": 9.584215832077374,
"netIncomePerEBTTTM": 0.8195655809324461,
"ebtPerEbitTTM": 1.0707728061915933,
"priceToFairValueTTM": 3.5710521360873093,
"debtToMarketCapTTM": 0,
"effectiveTaxRateTTM": 0.1804344190675539,
"enterpriseValueMultipleTTM": 9.175403867077376,
"dividendPerShareTTM": 0,
"revenue_history": [
{
"date": "2025",
"revenue": 5141242000
}
],
"dcf": {
"symbol": "INCY",
"date": "2026-10-19",
"dcf": 112.22630324964321,
"Stock Price": 113.07
},
"statements": {
"income": [
{
"date": "2025-12-31",
"symbol": "INCY",
"reportedCurrency": "USD",
"cik": "0000879169",
"filingDate": "2026-02-10",
"acceptedDate": "2026-02-10 16:01:52",
"fiscalYear": "2025",
"period": "FY",
"revenue": 5141242000,
"costOfRevenue": 372100000,
"grossProfit": 4769142000,
"researchAndDevelopmentExpenses": 2050152000,
"generalAndAdministrativeExpenses": 1376200000,
"sellingAndMarketingExpenses": 0,
"sellingGeneralAndAdministrativeExpenses": 1376200000,
"otherExpenses": 0,
"operatingExpenses": 3426352000,
"costAndExpenses": 3798452000,
"netInterestIncome": 103172000,
"interestIncome": 105600000,
"interestExpense": 2428000,
"depreciationAndAmortization": 93286000,
"ebitda": 1760165000,
"ebit": 1666879000,
"nonOperatingIncomeExcludingInterest": -324089000,
"operatingIncome": 1342790000,
"totalOtherIncomeExpensesNet": 321661000,
"incomeBeforeTax": 1664451000,
"incomeTaxExpense": 377801000,
"netIncomeFromContinuingOperations": 1286650000,
"netIncomeFromDiscontinuedOperations": 0,
"otherAdjustmentsToNetIncome": 0,
"netIncome": 1286650000,
"netIncomeDeductions": 0,
"bottomLineNetIncome": 1286650000,
"eps": 6.59,
"epsDiluted": 6.41,
"weightedAverageShsOut": 195204000,
"weightedAverageShsOutDil": 200700000
}
],
"balance_sheet": [
{
"date": "2025-12-31",
"symbol": "INCY",
"reportedCurrency": "USD",
"cik": "0000879169",
"filingDate": "2026-02-10",
"acceptedDate": "2026-02-10 16:01:52",
"fiscalYear": "2025",
"period": "FY",
"cashAndCashEquivalents": 3097817000,
"shortTermInvestments": 482787000,
"cashAndShortTermInvestments": 3580604000,
"netReceivables": 1024406999,
"accountsReceivables": 1024406999,
"otherReceivables": 0,
"inventory": 101060000,
"prepaids": 0,
"otherCurrentAssets": 317831000,
"totalCurrentAssets": 5023902000,
"propertyPlantEquipmentNet": 758405000,
"goodwill": 133000000,
"intangibleAssets": 117131000,
"goodwillAndIntangibleAssets": 250131000,
"longTermInvestments": 47991000,
"taxAssets": 515294000,
"otherNonCurrentAssets": -47991000,
"totalNonCurrentAssets": 1523830000,
"otherAssets": 385840000,
"totalAssets": 6957973000,
"totalPayables": 209938000,
"accountPayables": 209938000,
"otherPayables": 0,
"accruedExpenses": 228071000,
"shortTermDebt": 10213000,
"capitalLeaseObligationsCurrent": 0,
"taxPayables": 0,
"deferredRevenue": 0,
"otherCurrentLiabilities": 1066948000,
"totalCurrentLiabilities": 1515170000,
"longTermDebt": 14508000,
"capitalLeaseObligationsNonCurrent": 44707000,
"deferredRevenueNonCurrent": 0,
"deferredTaxLiabilitiesNonCurrent": 12878000,
"otherNonCurrentLiabilities": 216110000,
"totalNonCurrentLiabilities": 288203000,
"otherLiabilities": 0,
"capitalLeaseObligations": 44707000,
"totalLiabilities": 1803373000,
"treasuryStock": 0,
"preferredStock": 0,
"commonStock": 198000,
"retainedEarnings": 213769000,
"additionalPaidInCapital": 4928049000,
"accumulatedOtherComprehensiveIncomeLoss": 25462000,
"otherTotalStockholdersEquity": 0,
"totalStockholdersEquity": 5167478000,
"totalEquity": 5167478000,
"minorityInterest": 0,
"totalLiabilitiesAndTotalEquity": 6957973000,
"totalInvestments": 530778000,
"totalDebt": 69428000,
"netDebt": -3028389000
}
],
"cash_flow": [
{
"date": "2025-12-31",
"symbol": "INCY",
"reportedCurrency": "USD",
"cik": "0000879169",
"filingDate": "2026-02-10",
"acceptedDate": "2026-02-10 16:01:52",
"fiscalYear": "2025",
"period": "FY",
"netIncome": 1286650000,
"depreciationAndAmortization": 93286000,
"deferredIncomeTax": 247685000,
"stockBasedCompensation": 249346000,
"changeInWorkingCapital": -527162000,
"accountsReceivables": -170772000,
"inventory": -58513000,
"accountsPayables": 6562000,
"otherWorkingCapital": -304439000,
"otherNonCashItems": 63693000,
"netCashProvidedByOperatingActivities": 1413498000,
"investmentsInPropertyPlantAndEquipment": -83867000,
"acquisitionsNet": 0,
"purchasesOfInvestments": -303382000,
"salesMaturitiesOfInvestments": 284639000,
"otherInvestingActivities": 0,
"netCashProvidedByInvestingActivities": -102610000,
"netDebtIssuance": -4544000,
"longTermNetDebtIssuance": -4544000,
"shortTermNetDebtIssuance": 0,
"netStockIssuance": 202662000,
"netCommonStockIssuance": 202662000,
"commonStockIssuance": 221762000,
"commonStockRepurchased": -19100000,
"netPreferredStockIssuance": 0,
"netDividendsPaid": 0,
"commonDividendsPaid": 0,
"preferredDividendsPaid": 0,
"otherFinancingActivities": -97079000,
"netCashProvidedByFinancingActivities": 101039000,
"effectOfForexChangesOnCash": -1939000,
"netChangeInCash": 1409988000,
"cashAtEndOfPeriod": 3097817000,
"cashAtBeginningOfPeriod": 1687829000,
"operatingCashFlow": 1413498000,
"capitalExpenditure": -58867000,
"freeCashFlow": 1354631000,
"incomeTaxesPaid": 0,
"interestPaid": 0
}
]
}
}
Data:
{
"price": 113.05,
"rsi": 39.33190780528215,
"sma20": 116.92449999999992,
"sma50": 121.68379999999998,
"sma200": 107.57044999999998,
"adx": 26.530787582778736,
"atr": 3.19,
"atr_pct": 2.82,
"atr_expansion_pct": -4.7,
"di_plus": 11.2,
"di_minus": 38.5,
"high_52w": 129.93,
"low_52w": 83.8,
"structure": {
"ema8": 112.94346154840662,
"ema21": 116.04598497843297,
"ema50": 118.3075995009274,
"ema200": 108.68788794958817,
"ema10": 113.37428546830895,
"ema20": 115.83954666169896,
"ema10_slope_pct": -1.62,
"ema20_slope_pct": -2.05,
"trend_dir": "down",
"checks": {
"price_above_all": false,
"ema_stacked": false,
"ema21_rising": false,
"ema50_rising": false,
"adx_over_30": false,
"higher_highs_lows": false,
"lower_highs_lows": true,
"near_21ema": false
},
"dist_21ema_pct": -2.6,
"_no_bars": false,
"macd": {
"macd": -3.058,
"signal": -2.888,
"histogram": -0.171
},
"bollinger": {
"mid": 116.92,
"upper": 128.17,
"lower": 105.68,
"width_pct": 19.24
},
"crossover": {
"fresh_cross": false,
"pre_compressed": true,
"held_above_21": false,
"candles_since": 22,
"intraday_support": false
},
"momentum": {
"roc10": -0.9,
"ret_3d": 1.33,
"ret_5d": 1.52,
"roc10_accel": 9.84,
"checks": {
"roc_over_5": false,
"rsi_in_band": false,
"macd_expanding": false,
"top_quartile_3d": false,
"no_big_down": true,
"near_high": false
},
"volume": {
"rvol": 0.2,
"checks": {
"rvol_over_2": false,
"up_vol_beats_down": false,
"obv_new_high": false,
"surge_day": false,
"pullback_declining_vol": false,
"last_up_beats_down": true
}
}
},
"relative_strength": {
"sector": "Healthcare",
"sector_etf": "XLV",
"sector_etf_ret10d": 6.34,
"checks": {
"beats_spy_all": false,
"beats_sector_10d": false,
"rs_line_at_high": false,
"sector_top3": true
}
},
"commodity": {},
"universe": {
"checks": {
"price_over_20": true,
"mcap_2b_to_200b": true,
"dollar_vol_over_10m": true,
"common_stock": true,
"no_earnings_7d": true
},
"avg_dollar_vol": 196935654.7
},
"options": {
"checks": {
"call_vol_2x": false,
"ivr_under_40": false,
"oi_calls_above_price": false
},
"vals": {
"call_vol_mult": 0.2,
"iv_rank": 51.0
}
}
}
}
Data:
{
"prior_day": {
"high": 114.38,
"low": 112.71,
"close": 113.07,
"date": "2026-10-19"
},
"woodie_pivots": {
"PP": 113.31,
"R1": 113.9,
"S1": 112.23,
"R2": 114.98,
"S2": 111.64
},
"swing": {
"high_20d": 128.21,
"low_20d": 107.78,
"high_60d": 132.6,
"low_60d": 107.78
},
"orb": {
"high": 114.38,
"low": 113.03,
"date": "2026-10-19"
},
"vwap": 113.27,
"volume_profile": {
"poc": 113.37,
"vah": 120.82,
"val": 108.25,
"sessions": 20
},
"intraday": {
"h1_trend": "flat",
"h1_last": 113.08,
"h1_ema9": 113.13,
"h1_ema21": 112.95,
"m15_trend": "flat",
"m15_last": 113.09,
"m15_ema9": 113.16,
"m15_ema21": 113.13,
"rvol_intraday": 0.55,
"as_of_et": "2026-10-19 12:25"
},
"premarket": {
"date": "2026-10-19",
"high": 113.81,
"low": 112.35,
"last": 113.81,
"volume": 850,
"gap_pct": 0.65,
"path": "06:00 112.35 -> 08:25 113.08 -> 09:25 113.81",
"bars": 3,
"last_bar_et": "09:25"
},
"recent_daily": [
{
"d": "2026-09-15",
"o": 121.58,
"h": 122.19,
"l": 119.97,
"c": 121.74,
"v": 1564077.324269
},
{
"d": "2026-09-16",
"o": 121.48,
"h": 124.96,
"l": 121.48,
"c": 124.75,
"v": 1347302.054882
},
{
"d": "2026-09-17",
"o": 125.74,
"h": 127.74,
"l": 125.1,
"c": 127.62,
"v": 1468843.105161
},
{
"d": "2026-09-18",
"o": 127.85,
"h": 128.72,
"l": 125.23,
"c": 125.31,
"v": 3700438.542499
},
{
"d": "2026-09-21",
"o": 125,
"h": 127.41,
"l": 124.1893,
"c": 124.65,
"v": 1270531.629478
},
{
"d": "2026-09-22",
"o": 124.72,
"h": 127.75,
"l": 124.01,
"c": 126.93,
"v": 1647176.782498
},
{
"d": "2026-09-23",
"o": 127.51,
"h": 128.21,
"l": 123.89,
"c": 124.64,
"v": 1534432.26212
},
{
"d": "2026-09-24",
"o": 124.79,
"h": 125.5489,
"l": 123.03,
"c": 124.44,
"v": 1404535.944148
},
{
"d": "2026-09-25",
"o": 125.72,
"h": 126,
"l": 123.07,
"c": 123.89,
"v": 1210055.526199
},
{
"d": "2026-09-28",
"o": 123.32,
"h": 126.14,
"l": 122.5295,
"c": 124.82,
"v": 1436282.385754
},
{
"d": "2026-09-29",
"o": 123.67,
"h": 125.47,
"l": 121.89,
"c": 123.2,
"v": 1718561.945173
},
{
"d": "2026-09-30",
"o": 123,
"h": 124.2299,
"l": 121.03,
"c": 121.35,
"v": 1619920.312303
},
{
"d": "2026-10-01",
"o": 120.47,
"h": 121.22,
"l": 117,
"c": 117.14,
"v": 2364881.787424
},
{
"d": "2026-10-02",
"o": 116.76,
"h": 117.19,
"l": 114.57,
"c": 115.3,
"v": 2170193.393221
},
{
"d": "2026-10-05",
"o": 115.145,
"h": 115.67,
"l": 112.83,
"c": 114.13,
"v": 1948758.932533
},
{
"d": "2026-10-06",
"o": 114.13,
"h": 114.9651,
"l": 111.67,
"c": 112.73,
"v": 2459572.626831
},
{
"d": "2026-10-07",
"o": 112.82,
"h": 115.49,
"l": 112.455,
"c": 113.44,
"v": 1274765.262593
},
{
"d": "2026-10-08",
"o": 112.89,
"h": 113.75,
"l": 110.08,
"c": 112.75,
"v": 1927095.032519
},
{
"d": "2026-10-09",
"o": 112.35,
"h": 113.87,
"l": 111.805,
"c": 112.79,
"v": 1122154.796483
},
{
"d": "2026-10-12",
"o": 114.05,
"h": 114.05,
"l": 111.26,
"c": 111.36,
"v": 1478552.479369
},
{
"d": "2026-10-13",
"o": 111.29,
"h": 111.675,
"l": 107.7801,
"c": 108.62,
"v": 2589566.500434
},
{
"d": "2026-10-14",
"o": 108.61,
"h": 112.06,
"l": 107.83,
"c": 111.57,
"v": 1870089.164385
},
{
"d": "2026-10-15",
"o": 112.71,
"h": 116.03,
"l": 112.6,
"c": 113.27,
"v": 1940494.754623
},
{
"d": "2026-10-16",
"o": 113.98,
"h": 114.57,
"l": 112.02,
"c": 113.07,
"v": 1580667.060994
},
{
"d": "2026-10-19",
"o": 113.19,
"h": 114.38,
"l": 112.71,
"c": 113.07,
"v": 333151.695514
}
]
}
Data:
{
"sector": "Healthcare",
"etf": "XLV",
"etf_trend": "up",
"etf_r5d": 2.02,
"etf_rvol": 0.43,
"rs_5d": -1.78,
"leading": false
}
Data:
{
"estimates": [
{
"symbol": "INCY",
"date": "2030-12-31",
"revenueLow": 5215990532,
"revenueHigh": 5854918176,
"revenueAvg": 5473225692,
"ebitdaLow": 1421411492,
"ebitdaHigh": 1630365089,
"ebitdaAvg": 1505537439,
"ebitLow": 1295190207,
"ebitHigh": 1504143804,
"ebitAvg": 1379316154,
"netIncomeLow": 836736367,
"netIncomeHigh": 971980069,
"netIncomeAvg": 891186277,
"sgaExpenseLow": 1472335326,
"sgaExpenseHigh": 1652687598,
"sgaExpenseAvg": 1544945967,
"epsAvg": 4.44039,
"epsHigh": 4.84295,
"epsLow": 4.16909,
"numAnalystsRevenue": 9,
"numAnalystsEps": 5
},
{
"symbol": "INCY",
"date": "2029-12-31",
"revenueLow": 4767713565,
"revenueHigh": 5351729961,
"revenueAvg": 5002841208,
"ebitdaLow": 1096632792,
"ebitdaHigh": 1253482876,
"ebitdaAvg": 1159781517,
"ebitLow": 972823172,
"ebitHigh": 1129673256,
"ebitAvg": 1035971897,
"netIncomeLow": 628086639,
"netIncomeHigh": 729606720,
"netIncomeAvg": 668959194,
"sgaExpenseLow": 1345798668,
"sgaExpenseHigh": 1510650955,
"sgaExpenseAvg": 1412168944,
"epsAvg": 3.33313,
"epsHigh": 3.63531,
"epsLow": 3.12948,
"numAnalystsRevenue": 10,
"numAnalystsEps": 9
},
{
"symbol": "INCY",
"date": "2028-12-31",
"revenueLow": 5448335027,
"revenueHigh": 7664484637,
"revenueAvg": 6528025545,
"ebitdaLow": 2143103909,
"ebitdaHigh": 3697337772,
"ebitdaAvg": 3148132243,
"ebitLow": 2019389652,
"ebitHigh": 3573623515,
"ebitAvg": 3024417986,
"netIncomeLow": 1305469212,
"netIncomeHigh": 2311435820,
"netIncomeAvg": 1955966520,
"sgaExpenseLow": 1537919995,
"sgaExpenseHigh": 2163480057,
"sgaExpenseAvg": 1842687897,
"epsAvg": 8.93776,
"epsHigh": 11.51687,
"epsLow": 6.50458,
"numAnalystsRevenue": 18,
"numAnalystsEps": 12
},
{
"symbol": "INCY",
"date": "2027-12-31",
"revenueLow": 5967054604,
"revenueHigh": 6696909217,
"revenueAvg": 6213627109,
"ebitdaLow": 2348407989,
"ebitdaHigh": 2936805892,
"ebitdaAvg": 2920693509,
"ebitLow": 2234278270,
"ebitHigh": 2822676173,
"ebitAvg": 2806563790,
"netIncomeLow": 1444554313,
"netIncomeHigh": 1825390593,
"netIncomeAvg": 1814961970,
"sgaExpenseLow": 1684340728,
"sgaExpenseHigh": 1890359263,
"sgaExpenseAvg": 1753941584,
"epsAvg": 8.12298,
"epsHigh": 9.09512,
"epsLow": 7.19758,
"numAnalystsRevenue": 18,
"numAnalystsEps": 15
}
],
"price_target": {
"symbol": "INCY",
"targetHigh": 157,
"targetLow": 104,
"targetConsensus": 134.4,
"targetMedian": 130
},
"ratings": {
"symbol": "INCY",
"rating": "A+",
"overallScore": 4,
"discountedCashFlowScore": 5,
"returnOnEquityScore": 5,
"returnOnAssetsScore": 5,
"debtToEquityScore": 4,
"priceToEarningsScore": 3,
"priceToBookScore": 2
},
"grades": [
{
"symbol": "INCY",
"date": "2026-10-14",
"gradingCompany": "Truist Securities",
"previousGrade": "Hold",
"newGrade": "Hold",
"action": "maintain"
},
{
"symbol": "INCY",
"date": "2026-10-13",
"gradingCompany": "HC Wainwright & Co.",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "INCY",
"date": "2026-10-08",
"gradingCompany": "RBC Capital",
"previousGrade": "Sector Perform",
"newGrade": "Sector Perform",
"action": "maintain"
},
{
"symbol": "INCY",
"date": "2026-10-05",
"gradingCompany": "Stifel",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "INCY",
"date": "2026-10-01",
"gradingCompany": "Wells Fargo",
"previousGrade": "Equal Weight",
"newGrade": "Equal Weight",
"action": "maintain"
},
{
"symbol": "INCY",
"date": "2026-09-28",
"gradingCompany": "JP Morgan",
"previousGrade": "Neutral",
"newGrade": "Neutral",
"action": "maintain"
},
{
"symbol": "INCY",
"date": "2026-09-28",
"gradingCompany": "HC Wainwright & Co.",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "INCY",
"date": "2026-09-22",
"gradingCompany": "RBC Capital",
"previousGrade": "Sector Perform",
"newGrade": "Sector Perform",
"action": "maintain"
},
{
"symbol": "INCY",
"date": "2026-08-20",
"gradingCompany": "HC Wainwright & Co.",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "INCY",
"date": "2026-08-17",
"gradingCompany": "Piper Sandler",
"previousGrade": "Overweight",
"newGrade": "Overweight",
"action": "maintain"
},
{
"symbol": "INCY",
"date": "2026-08-04",
"gradingCompany": "Mizuho",
"previousGrade": "Outperform",
"newGrade": "Outperform",
"action": "maintain"
},
{
"symbol": "INCY",
"date": "2026-08-03",
"gradingCompany": "HC Wainwright & Co.",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "INCY",
"date": "2026-08-03",
"gradingCompany": "Leerink Partners",
"previousGrade": "Outperform",
"newGrade": "Outperform",
"action": "maintain"
},
{
"symbol": "INCY",
"date": "2026-07-29",
"gradingCompany": "Barclays",
"previousGrade": "Overweight",
"newGrade": "Overweight",
"action": "maintain"
},
{
"symbol": "INCY",
"date": "2026-07-29",
"gradingCompany": "RBC Capital",
"previousGrade": "Sector Perform",
"newGrade": "Sector Perform",
"action": "maintain"
},
{
"symbol": "INCY",
"date": "2026-07-29",
"gradingCompany": "Guggenheim",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "INCY",
"date": "2026-07-29",
"gradingCompany": "HC Wainwright & Co.",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "INCY",
"date": "2026-07-29",
"gradingCompany": "BMO Capital",
"previousGrade": "Market Perform",
"newGrade": "Market Perform",
"action": "maintain"
},
{
"symbol": "INCY",
"date": "2026-07-23",
"gradingCompany": "Morgan Stanley",
"previousGrade": "Equal Weight",
"newGrade": "Equal Weight",
"action": "maintain"
},
{
"symbol": "INCY",
"date": "2026-07-23",
"gradingCompany": "JP Morgan",
"previousGrade": "Neutral",
"newGrade": "Neutral",
"action": "maintain"
},
{
"symbol": "INCY",
"date": "2026-07-21",
"gradingCompany": "HC Wainwright & Co.",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "INCY",
"date": "2026-07-14",
"gradingCompany": "Barclays",
"previousGrade": "Overweight",
"newGrade": "Overweight",
"action": "maintain"
},
{
"symbol": "INCY",
"date": "2026-07-13",
"gradingCompany": "BMO Capital",
"previousGrade": "Market Perform",
"newGrade": "Market Perform",
"action": "maintain"
},
{
"symbol": "INCY",
"date": "2026-07-07",
"gradingCompany": "RBC Capital",
"previousGrade": "Sector Perform",
"newGrade": "Sector Perform",
"action": "maintain"
},
{
"symbol": "INCY",
"date": "2026-06-29",
"gradingCompany": "HC Wainwright & Co.",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "INCY",
"date": "2026-06-26",
"gradingCompany": "UBS",
"previousGrade": "Neutral",
"newGrade": "Neutral",
"action": "maintain"
},
{
"symbol": "INCY",
"date": "2026-06-24",
"gradingCompany": "HC Wainwright & Co.",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "INCY",
"date": "2026-06-22",
"gradingCompany": "Truist Securities",
"previousGrade": "Hold",
"newGrade": "Hold",
"action": "maintain"
},
{
"symbol": "INCY",
"date": "2026-06-22",
"gradingCompany": "BMO Capital",
"previousGrade": "Underperform",
"newGrade": "Market Perform",
"action": "upgrade"
},
{
"symbol": "INCY",
"date": "2026-06-09",
"gradingCompany": "HC Wainwright & Co.",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "INCY",
"date": "2026-05-21",
"gradingCompany": "HC Wainwright & Co.",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "INCY",
"date": "2026-05-04",
"gradingCompany": "HC Wainwright & Co.",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "INCY",
"date": "2026-04-29",
"gradingCompany": "Stifel",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "INCY",
"date": "2026-04-29",
"gradingCompany": "Oppenheimer",
"previousGrade": "Perform",
"newGrade": "Perform",
"action": "maintain"
},
{
"symbol": "INCY",
"date": "2026-04-15",
"gradingCompany": "HC Wainwright & Co.",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "INCY",
"date": "2026-03-30",
"gradingCompany": "HC Wainwright & Co.",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "INCY",
"date": "2026-03-25",
"gradingCompany": "HC Wainwright & Co.",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "INCY",
"date": "2026-03-25",
"gradingCompany": "UBS",
"previousGrade": "Neutral",
"newGrade": "Neutral",
"action": "maintain"
},
{
"symbol": "INCY",
"date": "2026-03-16",
"gradingCompany": "Jefferies",
"previousGrade": "Buy",
"newGrade": "Hold",
"action": "downgrade"
},
{
"symbol": "INCY",
"date": "2026-03-09",
"gradingCompany": "HC Wainwright & Co.",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "INCY",
"date": "2026-03-05",
"gradingCompany": "Evercore ISI Group",
"previousGrade": "In Line",
"newGrade": "In Line",
"action": "maintain"
},
{
"symbol": "INCY",
"date": "2026-02-18",
"gradingCompany": "Barclays",
"previousGrade": "Overweight",
"newGrade": "Overweight",
"action": "maintain"
},
{
"symbol": "INCY",
"date": "2026-02-11",
"gradingCompany": "HC Wainwright & Co.",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "INCY",
"date": "2026-02-11",
"gradingCompany": "Stifel",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "INCY",
"date": "2026-02-11",
"gradingCompany": "RBC Capital",
"previousGrade": "Sector Perform",
"newGrade": "Sector Perform",
"action": "maintain"
},
{
"symbol": "INCY",
"date": "2026-02-11",
"gradingCompany": "Wells Fargo",
"previousGrade": "Equal Weight",
"newGrade": "Equal Weight",
"action": "maintain"
},
{
"symbol": "INCY",
"date": "2026-02-06",
"gradingCompany": "Piper Sandler",
"previousGrade": "Overweight",
"newGrade": "Overweight",
"action": "maintain"
},
{
"symbol": "INCY",
"date": "2026-02-04",
"gradingCompany": "Barclays",
"previousGrade": "Overweight",
"newGrade": "Overweight",
"action": "maintain"
},
{
"symbol": "INCY",
"date": "2026-01-20",
"gradingCompany": "Wells Fargo",
"previousGrade": "Overweight",
"newGrade": "Equal Weight",
"action": "downgrade"
},
{
"symbol": "INCY",
"date": "2026-01-13",
"gradingCompany": "TD Cowen",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "INCY",
"date": "2026-01-06",
"gradingCompany": "Morgan Stanley",
"previousGrade": "Equal Weight",
"newGrade": "Equal Weight",
"action": "maintain"
},
{
"symbol": "INCY",
"date": "2025-12-08",
"gradingCompany": "Morgan Stanley",
"previousGrade": "Equal Weight",
"newGrade": "Equal Weight",
"action": "maintain"
},
{
"symbol": "INCY",
"date": "2025-12-08",
"gradingCompany": "Wells Fargo",
"previousGrade": "Overweight",
"newGrade": "Overweight",
"action": "maintain"
},
{
"symbol": "INCY",
"date": "2025-12-08",
"gradingCompany": "Mizuho",
"previousGrade": "Neutral",
"newGrade": "Outperform",
"action": "upgrade"
},
{
"symbol": "INCY",
"date": "2025-11-24",
"gradingCompany": "Barclays",
"previousGrade": "Overweight",
"newGrade": "Overweight",
"action": "maintain"
},
{
"symbol": "INCY",
"date": "2025-11-04",
"gradingCompany": "Piper Sandler",
"previousGrade": "Overweight",
"newGrade": "Overweight",
"action": "maintain"
},
{
"symbol": "INCY",
"date": "2025-11-03",
"gradingCompany": "Guggenheim",
"previousGrade": "Neutral",
"newGrade": "Buy",
"action": "upgrade"
},
{
"symbol": "INCY",
"date": "2025-10-29",
"gradingCompany": "Truist Securities",
"previousGrade": "Hold",
"newGrade": "Hold",
"action": "maintain"
},
{
"symbol": "INCY",
"date": "2025-10-29",
"gradingCompany": "RBC Capital",
"previousGrade": "Sector Perform",
"newGrade": "Sector Perform",
"action": "maintain"
},
{
"symbol": "INCY",
"date": "2025-10-29",
"gradingCompany": "Barclays",
"previousGrade": "Overweight",
"newGrade": "Overweight",
"action": "maintain"
},
{
"symbol": "INCY",
"date": "2025-10-29",
"gradingCompany": "Wells Fargo",
"previousGrade": "Overweight",
"newGrade": "Overweight",
"action": "maintain"
}
]
}
Data:
[
{
"title": "Incyte to Highlight Key Oncology Data Presentations at the European Society for Medical Oncology (ESMO) Congress 2026",
"url": "https://www.gurufocus.com/news/9129091/incyte-to-highlight-key-oncology-data-presentations-at-the-european-society-for-medical-oncology-esmo-congress-2026",
"source": "GuruFocus",
"date": "2026-10-18 19:00:00",
"summary": "Incyte (Nasdaq:INCY) today announced that it will present new data from its oncology portfolio during the European Society of Medical Oncology (ESMO) Congress 2",
"image": "https://images.financialmodelingprep.com/news/incyte-to-highlight-key-oncology-data-presentations-at-the-20261018.png"
},
{
"title": "7,443 Incyte Corporation $INCY Shares Bought by Farther Finance Advisors LLC",
"url": "https://www.defenseworld.net/2026/10/17/7443-incyte-corporation-incy-shares-bought-by-farther-finance-advisors-llc.html",
"source": "Defense World",
"date": "2026-10-17 03:37:15",
"summary": "Farther Finance Advisors LLC grew its holdings in Incyte Corporation (NASDAQ: INCY) by 410.5% during the undefined quarter, according to the company in its most recent disclosure with the SEC. The fund owned 9,256 shares of the biopharmaceutical company's stock after purchasing a",
"image": "https://images.financialmodelingprep.com/news/7443-incyte-corporation-incy-shares-bought-by-farther-finance-20261017.png"
},
{
"title": "Incyte Honors the 2026 MPN Heroes\u00ae, Celebrating Champions of the Myeloproliferative Neoplasm (MPN) Community",
"url": "https://www.businesswire.com/news/home/20261013181448/en/Incyte-Honors-the-2026-MPN-Heroes%C2%AE-Celebrating-Champions-of-the-Myeloproliferative-Neoplasm-MPN-Community/",
"source": "Business Wire",
"date": "2026-10-13 13:49:00",
"summary": "WILMINGTON, Del.--(BUSINESS WIRE)--Incyte today announced eight winners of the 2026 MPN Heroes\u00ae annual recognition program. The program, now in its 14th year, pays tribute to individuals whose contributions to patient care, research and advocacy make a meaningful difference for p",
"image": "https://images.financialmodelingprep.com/news/incyte-honors-the-2026-mpn-heroes-celebrating-champions-of-20261013.jpg"
},
{
"title": "Incyte to Report Third Quarter Financial Results",
"url": "https://www.gurufocus.com/news/9115322/incyte-to-report-third-quarter-financial-results",
"source": "GuruFocus",
"date": "2026-10-08 09:00:00",
"summary": "Incyte (Nasdaq:INCY) announced today that it has scheduled its third quarter financial results conference call and webcast for 8:00 a.m. ET on Thursday, October",
"image": "https://images.financialmodelingprep.com/news/incyte-to-report-third-quarter-financial-results-20261008.png"
},
{
"title": "Knight Therapeutics Announces Regulatory Approval of NIKTIMVO\u00ae in Brazil",
"url": "https://www.globenewswire.com/news-release/2026/10/06/3375375/0/en/knight-therapeutics-announces-regulatory-approval-of-niktimvo-in-brazil.html",
"source": "GlobeNewsWire",
"date": "2026-10-06 07:35:00",
"summary": "MONTREAL, Oct. 06, 2026 (GLOBE NEWSWIRE) -- Knight Therapeutics Inc. (\"Knight\") (TSX: GUD), a pan-American (ex-US) pharmaceutical company, announced today it has received expedited regulatory approval under ANVISA's rare disease pathway for NIKTIMVO\u00ae (axatilimab), for the treatme",
"image": "https://images.financialmodelingprep.com/news/knight-therapeutics-announces-regulatory-approval-of-niktimvo-in-brazil-20261006.jpg"
},
{
"title": "Stifel raises Incyte stock price target on pipeline potential By Investing.com",
"url": "https://www.investing.com/news/analyst-ratings/stifel-raises-incyte-stock-price-target-on-pipeline-potential-93CH-4931495",
"source": "Investing.com",
"date": "2026-10-05T10:14:58Z",
"summary": "Investing.com - Stifel raised its price target on Incyte Corp. shares (NASDAQ:INCY) to $157 from $145 while maintaining a Buy rating on the stock. The company currently trades at a P/E ratio of 14.6 with a notably low PEG ratio of 0.18, and InvestingPro analysis indicates the sto",
"image": "https://content-media.investing.com/news/moved_LYNXMPEM4519D_1200_L.jpg"
},
{
"title": "INCY or TECH: Which Is the Better Value Stock Right Now?",
"url": "https://www.zacks.com/stock/news/2998308/incy-or-tech-which-is-the-better-value-stock-right-now?cid=CS-ZC-FT-fundamental_analysis|yseop_template_3-2998308",
"source": "Zacks Investment Research",
"date": "2026-09-30T14:40:02Z",
"summary": "A comparison of two medical-biomedical and genetics stocks reveals that Incyte (INCY) is the more attractive value investment option. INCY holds a Zacks Rank #2 (Buy) with improving earnings outlook and a Value grade of B, while Techne (TECH) has a Zacks Rank #3 (Hold) and Value ",
"image": "https://staticx-tuner.zacks.com/images/default_article_images/default226.jpg"
},
{
"title": "MIRM Secures FDA Nod for an Ultra-Rare Bone Disorder Therapy",
"url": "https://www.zacks.com/stock/news/2996863/mirm-secures-fda-nod-for-an-ultra-rare-bone-disorder-therapy?cid=CS-STOCKNEWSAPI-FT-analyst_blog|company_news_medical_sector-2996863",
"source": "Zacks Investment Research",
"date": "2026-09-28 12:46:18",
"summary": "Mirum Pharmaceuticals wins FDA approval for Atebrioz in FOP, backed by PROGRESS data showing a reduction in new HO lesion volume.",
"image": "https://images.financialmodelingprep.com/news/mirm-secures-fda-nod-for-an-ultrarare-bone-disorder-20260928.jpg"
},
{
"title": "MiniMed appoints Sheila Denton as General Counsel & Corporate Secretary",
"url": "https://www.prnewswire.com/news-releases/minimed-appoints-sheila-denton-as-general-counsel--corporate-secretary-302891089.html",
"source": "PRNewsWire",
"date": "2026-09-28 09:03:00",
"summary": "NORTHRIDGE, Calif., Sept. 28, 2026 /PRNewswire/ -- MiniMed (Nasdaq: MMED), a global leader in diabetes technology, today announced that Sheila Denton has been named General Counsel & Corporate Secretary.",
"image": "https://images.financialmodelingprep.com/news/minimed-appoints-sheila-denton-as-general-counsel-corporate-secretary-20260928.jpg"
},
{
"title": "FDA approves Atebrioz for rare bone disease fibrodysplasia ossificans progressiva By Investing.com",
"url": "https://www.investing.com/news/company-news/fda-approves-atebrioz-for-rare-bone-disease-fibrodysplasia-ossificans-progressiva-93CH-4918289",
"source": "Investing.com",
"date": "2026-09-25T23:04:36Z",
"summary": "FOSTER CITY, Calif. & WILMINGTON, Del. - Mirum Pharmaceuticals (NASDAQ:MIRM) and Incyte (NASDAQ:INCY) announced today that the U.S. Food and Drug Administration has approved Atebrioz (zilurgisertib) tablets to reduce the volume of total new heterotopic ossification in adult and p",
"image": "https://content-media.investing.com/news/LYNXMPEM5F17R_1200_L.jpg"
},
{
"title": "Mirum Pharmaceuticals and Incyte Announce U.S. FDA Approval of Atebrioz\u2122 (zilurgisertib) for Adult and Pediatric Patients with Fibrodysplasia Ossificans Progressiva",
"url": "https://www.businesswire.com/news/home/20260925436454/en/Mirum-Pharmaceuticals-and-Incyte-Announce-U.S.-FDA-Approval-of-Atebrioz%E2%84%A2-zilurgisertib-for-Adult-and-Pediatric-Patients-with-Fibrodysplasia-Ossificans-Progressiva/",
"source": "Business Wire",
"date": "2026-09-25 19:00:00",
"summary": "FOSTER CITY, Calif. & WILMINGTON, Del.--(BUSINESS WIRE)--Mirum and Incyte Announce U.S. FDA Approval of Atebrioz\u2122 (zilurgisertib) for Adult and Pediatric Patients with Fibrodysplasia Ossificans Progressiva.",
"image": "https://images.financialmodelingprep.com/news/mirum-pharmaceuticals-and-incyte-announce-us-fda-approval-of-20260925.jpg"
},
{
"title": "How Is Incyte's Stock Performance Compared to Other Biotech Stocks?",
"url": "https://finance.yahoo.com/healthcare/articles/incyte-stock-performance-compared-other-045305372.html",
"source": "Yahoo! Finance",
"date": "2026-09-23T04:53:05Z",
"summary": "Based in Wilmington, Delaware, Incyte Corporation (INCY) is a global biopharmaceutical company that discovers, develops, and commercializes innovative treatments for cancer, blood disorders, and immune-mediated diseases.\n\nThe company's marketed therapies include JAKAFI for blood ",
"image": "https://s.yimg.com/lo/mysterio/api/86a01d1e5e060f9d7520b280e835ea48bc9442a51262d9aac7fff27083552ea8/lightyear_networkapi/resizefill_w1200%3Bquality_80%3Bformat_webp/https%3A%2F%2Fmedia.zenfs.com%2Fen%2Fbarchart_com_477%2Fa7b020b03516dbea711f7df52035e3ce.jpg"
},
{
"title": "Incyte to present inflammation and autoimmunity data at EADV By Investing.com",
"url": "https://www.investing.com/news/company-news/incyte-to-present-inflammation-and-autoimmunity-data-at-eadv-93CH-4910821",
"source": "Investing.com",
"date": "2026-09-22T12:36:34Z",
"summary": "WILMINGTON, Del. - Incyte (NASDAQ:INCY) announced Monday that data from its inflammation and autoimmunity portfolio will be presented at the European Academy of Dermatology and Venereology Congress, scheduled for September 30 through October 3 in Vienna, Austria.\n\nThe presentatio",
"image": "https://content-media.investing.com/news/LYNXMPEM0J0ZC_1200_L.jpg"
},
{
"title": "Incyte Data at the European Academy of Dermatology and Venereology (EADV) Congress Underscore the Breadth of Incyte's Inflammation and Autoimmunity Portfolio",
"url": "https://www.businesswire.com/news/home/20260922373347/en/Incyte-Data-at-the-European-Academy-of-Dermatology-and-Venereology-EADV-Congress-Underscore-the-Breadth-of-Incyte%E2%80%99s-Inflammation-and-Autoimmunity-Portfolio/",
"source": "Business Wire",
"date": "2026-09-22 08:30:00",
"summary": "WILMINGTON, Del.--(BUSINESS WIRE)---- $INCY--Incyte Data at the 2026 EADV Congress Underscore the Breadth of Incyte's Inflammation and Autoimmunity Portfolio.",
"image": "https://images.financialmodelingprep.com/news/incyte-data-at-the-european-academy-of-dermatology-and-20260922.jpg"
},
{
"title": "Is First Trust Large Cap Growth AlphaDEX ETF (FTC) a Strong ETF Right Now?",
"url": "https://www.zacks.com/stock/news/2993405/is-first-trust-large-cap-growth-alphadex-etf-ftc-a-strong-etf-right-now?cid=CS-STOCKNEWSAPI-FT-smart_beta_etf-2993405",
"source": "Zacks Investment Research",
"date": "2026-09-22 07:21:15",
"summary": "The First Trust Large Cap Growth AlphaDEX ETF (FTC) was launched on 05/08/2007, and is a smart beta exchange traded fund designed to offer broad exposure to the Style Box - Large Cap Growth category of the market.",
"image": "https://images.financialmodelingprep.com/news/is-first-trust-large-cap-growth-alphadex-etf-ftc-20260922.jpg"
},
{
"title": "Incyte Maps Post-JAKAFI Growth With Pipeline Push and $4B Sales Target",
"url": "https://www.defenseworld.net/2026/09/21/incyte-maps-post-jakafi-growth-with-pipeline-push-and-4b-sales-target.html",
"source": "Defense World",
"date": "2026-09-21 02:03:16",
"summary": "Incyte (NASDAQ: INCY) executives outlined a strategy centered on expanding its non-JAKAFI business, advancing a broader late-stage pipeline and preparing for the loss of exclusivity for JAKAFI after 2029. Chief Executive Officer Bill Meury said the company's pipeline has changed ",
"image": "https://images.financialmodelingprep.com/news/incyte-maps-postjakafi-growth-with-pipeline-push-and-4b-20260921.png"
},
{
"title": "Specialised Therapeutics expands Incyte partnership to Australia By Investing.com",
"url": "https://www.investing.com/news/company-news/specialised-therapeutics-expands-incyte-partnership-to-australia-93CH-4908193",
"source": "Investing.com",
"date": "2026-09-20T20:04:37Z",
"summary": "SINGAPORE - Specialised Therapeutics announced today an expansion of its partnership with Incyte Biosciences International, an affiliate of Incyte (NASDAQ:INCY), to commercialize ruxolitinib cream in Australia.\n\nRuxolitinib cream is a topical Janus kinase inhibitor registered as ",
"image": "https://content-media.investing.com/news/LYNXMPEM3115H_1200_L.jpg"
},
{
"title": "Specialised Therapeutics Expands Partnership with Incyte to Include Ruxolitinib Cream (Opzelura\u00ae) in Australia",
"url": "https://www.prnewswire.com/news-releases/specialised-therapeutics-expands-partnership-with-incyte-to-include-ruxolitinib-cream-opzelura-in-australia-302882999.html",
"source": "PRNewsWire",
"date": "2026-09-20 16:00:00",
"summary": "/PRNewswire/ -- Independent biopharmaceutical company Specialised Therapeutics (ST) today announced an expansion of its existing partnership with Incyte",
"image": "https://images.financialmodelingprep.com/news/specialised-therapeutics-expands-partnership-with-incyte-to-include-ruxolitinib-20260920.jpg"
},
{
"title": "Incyte Bets $1.25 Billion On Rare Bleeding Disorder Drug With Blockbuster Potential",
"url": "https://www.benzinga.com/news/health-care/26/06/53098895/incyte-bets-1-25-billion-on-rare-bleeding-disorder-drug-with-blockbuster-potential?utm_source=benzinga_taxonomy&utm_medium=rss_feed_free&utm_content=taxonomy_rss&utm_campaign=channel",
"source": "Benzinga",
"date": "2026-06-09T18:08:29Z",
"summary": "Incyte Corporation agreed to acquire Vega Therapeutics for $1.25 billion upfront to add VGA039, a late-stage monoclonal antibody candidate for von Willebrand disease, to its hematology portfolio. The deal could reach $2 billion with milestone payments. VGA039, in Phase 3 developm",
"image": "https://cdn.benzinga.com/cdn-cgi/image/width=1200,height=800,fit=crop/files/images/story/2026/06/09/Konskie--Poland---December-08--2024-Incy.jpeg"
}
]
Data:
[
{
"symbol": "INCY",
"date": "2026-10-29",
"epsActual": null,
"epsEstimated": -3.57,
"revenueActual": null,
"revenueEstimated": 1471938000,
"lastUpdated": "2026-10-19"
},
{
"symbol": "INCY",
"date": "2026-07-28",
"epsActual": 3.09,
"epsEstimated": 2.15,
"revenueActual": 1674039000,
"revenueEstimated": 1503905000,
"lastUpdated": "2026-10-19"
},
{
"symbol": "INCY",
"date": "2026-04-28",
"epsActual": 1.81,
"epsEstimated": 1.34,
"revenueActual": 1272676000,
"revenueEstimated": 1216002000,
"lastUpdated": "2026-07-28"
},
{
"symbol": "INCY",
"date": "2026-02-10",
"epsActual": 1.8,
"epsEstimated": 1.9,
"revenueActual": 1506835000,
"revenueEstimated": 1354821000,
"lastUpdated": "2026-05-10"
},
{
"symbol": "INCY",
"date": "2025-10-28",
"epsActual": 2.26,
"epsEstimated": 1.66,
"revenueActual": 1365980000,
"revenueEstimated": 1354251190,
"lastUpdated": "2026-01-28"
}
]
Data:
{
"borrow": [],
"short_interest": [
{
"symbol": "INCY",
"file_date": "",
"error": "Symbol not found in FINRA biweekly file",
"days_to_cover": null
}
],
"ftd": {
"symbol": "INCY",
"periods": [
{
"file_period": "202607a",
"settlement_date": "20260701",
"quantity_fails": 441,
"price": 113.36
},
{
"file_period": "202607b",
"settlement_date": "20260731",
"quantity_fails": 11788,
"price": 122.99
},
{
"file_period": "202608a",
"settlement_date": "20260811",
"quantity_fails": 951,
"price": 121.55
},
{
"file_period": "202608b",
"settlement_date": "20260831",
"quantity_fails": 7,
"price": 124.37
},
{
"file_period": "202609a",
"settlement_date": "20260910",
"quantity_fails": 62826,
"price": 126.01
},
{
"file_period": "202609b",
"settlement_date": "20260924",
"quantity_fails": 1,
"price": 124.64
}
],
"trend": "falling",
"trend_description": "FTD quantity declining \u2014 shorts covering or delivery improving"
}
}
Data:
{
"insider": [
{
"symbol": "INCY",
"filingDate": "2026-10-05",
"transactionDate": "2026-10-01",
"reportingCik": "0002039219",
"companyCik": "0000879169",
"transactionType": "F-InKind",
"securitiesOwned": 37578,
"reportingName": "Heeson Lee",
"typeOfOwner": "officer: EVP, Head of Incyte Intl",
"acquisitionOrDisposition": "D",
"directOrIndirect": "D",
"formType": "4",
"securitiesTransacted": 463,
"price": 117.14,
"securityName": "Common Stock",
"url": "https://www.sec.gov/Archives/edgar/data/879169/000203921926000010/0002039219-26-000010-index.htm"
},
{
"symbol": "INCY",
"filingDate": "2026-10-02",
"transactionDate": "2026-09-30",
"reportingCik": "0001263508",
"companyCik": "0000879169",
"transactionType": "A-Award",
"securitiesOwned": 28206082,
"reportingName": "BAKER BROS. ADVISORS LP",
"typeOfOwner": "director, 10 percent owner: ",
"acquisitionOrDisposition": "A",
"directOrIndirect": "I",
"formType": "4",
"securitiesTransacted": 322,
"price": 0,
"securityName": "Common Stock",
"url": "https://www.sec.gov/Archives/edgar/data/879169/000119312526412653/0001193125-26-412653-index.htm"
},
{
"symbol": "INCY",
"filingDate": "2026-10-02",
"transactionDate": "2026-09-30",
"reportingCik": "0001263508",
"companyCik": "0000879169",
"transactionType": "A-Award",
"securitiesOwned": 2835403,
"reportingName": "BAKER BROS. ADVISORS LP",
"typeOfOwner": "director, 10 percent owner: ",
"acquisitionOrDisposition": "A",
"directOrIndirect": "I",
"formType": "4",
"securitiesTransacted": 322,
"price": 0,
"securityName": "Common Stock",
"url": "https://www.sec.gov/Archives/edgar/data/879169/000119312526412653/0001193125-26-412653-index.htm"
},
{
"symbol": "INCY",
"filingDate": "2026-10-02",
"transactionDate": "2026-09-30",
"reportingCik": "0001409601",
"companyCik": "0000879169",
"transactionType": "A-Award",
"securitiesOwned": 25838,
"reportingName": "Clancy Paul J",
"typeOfOwner": "director",
"acquisitionOrDisposition": "A",
"directOrIndirect": "D",
"formType": "4",
"securitiesTransacted": 203,
"price": 121.35,
"securityName": "Common Stock",
"url": "https://www.sec.gov/Archives/edgar/data/879169/000140960126000015/0001409601-26-000015-index.htm"
},
{
"symbol": "INCY",
"filingDate": "2026-10-02",
"transactionDate": "2026-09-30",
"reportingCik": "0001177917",
"companyCik": "0000879169",
"transactionType": "A-Award",
"securitiesOwned": 23225,
"reportingName": "HARRIGAN EDMUND",
"typeOfOwner": "director",
"acquisitionOrDisposition": "A",
"directOrIndirect": "D",
"formType": "4",
"securitiesTransacted": 206,
"price": 121.35,
"securityName": "Common Stock",
"url": "https://www.sec.gov/Archives/edgar/data/879169/000117791726000014/0001177917-26-000014-index.htm"
},
{
"symbol": "INCY",
"filingDate": "2026-09-24",
"transactionDate": "2026-09-22",
"reportingCik": "0002085970",
"companyCik": "0000879169",
"transactionType": "F-InKind",
"securitiesOwned": 15904,
"reportingName": "Gardner David H",
"typeOfOwner": "officer: EVP, Chief Strategy Officer",
"acquisitionOrDisposition": "D",
"directOrIndirect": "D",
"formType": "4",
"securitiesTransacted": 920,
"price": 126.93,
"securityName": "Common Stock",
"url": "https://www.sec.gov/Archives/edgar/data/879169/000208597026000007/0002085970-26-000007-index.htm"
},
{
"symbol": "INCY",
"filingDate": "2026-09-17",
"transactionDate": "2026-09-15",
"reportingCik": "0001205703",
"companyCik": "0000879169",
"transactionType": "M-Exempt",
"securitiesOwned": 206418,
"reportingName": "CAGNONI PABLO J",
"typeOfOwner": "officer: President, Global Head of R&D",
"acquisitionOrDisposition": "A",
"directOrIndirect": "D",
"formType": "4",
"securitiesTransacted": 9233,
"price": 71.93,
"securityName": "Common Stock",
"url": "https://www.sec.gov/Archives/edgar/data/879169/000120570326000030/0001205703-26-000030-index.htm"
},
{
"symbol": "INCY",
"filingDate": "2026-09-17",
"transactionDate": "2026-09-15",
"reportingCik": "0001205703",
"companyCik": "0000879169",
"transactionType": "M-Exempt",
"securitiesOwned": 197185,
"reportingName": "CAGNONI PABLO J",
"typeOfOwner": "officer: President, Global Head of R&D",
"acquisitionOrDisposition": "A",
"directOrIndirect": "D",
"formType": "4",
"securitiesTransacted": 6477,
"price": 64.25,
"securityName": "Common Stock",
"url": "https://www.sec.gov/Archives/edgar/data/879169/000120570326000030/0001205703-26-000030-index.htm"
}
],
"congress": [
{
"symbol": "INCY",
"senateID": "C001047",
"disclosureDate": "2018-12-08",
"transactionDate": "2018-11-12",
"firstName": "Shelley Moore",
"lastName": "Capito",
"office": "Shelley M Capito",
"district": "WV",
"owner": "Spouse",
"assetDescription": "Incyte Corporation",
"assetType": "Stock",
"type": "Sale (Full)",
"amount": "$1,001 - $15,000",
"capitalGainsOver200USD": "False",
"comment": "",
"link": "https://efdsearch.senate.gov/search/view/ptr/2969d359-4901-4bd8-a92d-74fbf37573e6/"
},
{
"symbol": "INCY",
"senateID": "C001047",
"disclosureDate": "2017-10-06",
"transactionDate": "2017-09-08",
"firstName": "Shelley Moore",
"lastName": "Capito",
"office": "Shelley M Capito",
"district": "WV",
"owner": "Spouse",
"assetDescription": "Incyte Corporation",
"assetType": "Stock",
"type": "Purchase",
"amount": "$1,001 - $15,000",
"capitalGainsOver200USD": "False",
"comment": "",
"link": "https://efdsearch.senate.gov/search/view/ptr/2697b867-b20d-47be-98d3-a8d19339b36d/"
},
{
"symbol": "INCY",
"senateID": "K000389",
"disclosureDate": "2026-10-09",
"transactionDate": "2026-09-04",
"firstName": "Ro",
"lastName": "Khanna",
"office": "Ro Khanna",
"district": "CA17",
"owner": "Spouse",
"assetDescription": "Incyte Corp",
"assetType": "Stock",
"type": "Purchase",
"amount": "$1,001 - $15,000",
"capitalGainsOver200USD": "False",
"comment": "",
"link": "https://disclosures-clerk.house.gov/public_disc/ptr-pdfs/2026/9116376.pdf"
},
{
"symbol": "INCY",
"senateID": "B001327",
"disclosureDate": "2025-06-02",
"transactionDate": "2025-05-15",
"firstName": "Robert P.",
"lastName": "Bresnahan",
"office": "Rob Bresnahan",
"district": "PA08",
"owner": "",
"assetDescription": "Incyte Corporation - Common Stock",
"assetType": "Stock",
"type": "Sale (Full)",
"amount": "$1,001 - $15,000",
"capitalGainsOver200USD": "False",
"comment": "",
"link": "https://disclosures-clerk.house.gov/public_disc/ptr-pdfs/2025/20030433.pdf"
},
{
"symbol": "INCY",
"senateID": "K000389",
"disclosureDate": "2024-10-08",
"transactionDate": "2024-09-09",
"firstName": "Ro",
"lastName": "Khanna",
"office": "Ro Khanna",
"district": "CA17",
"owner": "Spouse",
"assetDescription": "Incyte Corp",
"assetType": "Stock",
"type": "Sale",
"amount": "$1,001 - $15,000",
"capitalGainsOver200USD": "False",
"comment": "",
"link": "https://disclosures-clerk.house.gov/public_disc/ptr-pdfs/2024/8220660.pdf"
},
{
"symbol": "INCY",
"senateID": "K000389",
"disclosureDate": "2024-04-05",
"transactionDate": "2024-03-25",
"firstName": "Ro",
"lastName": "Khanna",
"office": "Ro Khanna",
"district": "CA17",
"owner": "",
"assetDescription": "Incyte Corp",
"assetType": "Stock",
"type": "Purchase",
"amount": "$1,001 - $15,000",
"capitalGainsOver200USD": "False",
"comment": "",
"link": "https://disclosures-clerk.house.gov/public_disc/ptr-pdfs/2024/8220192.pdf"
},
{
"symbol": "INCY",
"senateID": "K000389",
"disclosureDate": "2023-11-08",
"transactionDate": "2023-10-02",
"firstName": "Ro",
"lastName": "Khanna",
"office": "Ro Khanna",
"district": "CA17",
"owner": "",
"assetDescription": "Incyte Corp",
"assetType": "Stock",
"type": "Sale",
"amount": "$1,001 - $15,000",
"capitalGainsOver200USD": "False",
"comment": "",
"link": "https://disclosures-clerk.house.gov/public_disc/ptr-pdfs/2023/8220039.pdf"
},
{
"symbol": "INCY",
"senateID": "K000389",
"disclosureDate": "2023-11-08",
"transactionDate": "2023-10-10",
"firstName": "Ro",
"lastName": "Khanna",
"office": "Ro Khanna",
"district": "CA17",
"owner": "Spouse",
"assetDescription": "Incyte Corp",
"assetType": "Stock",
"type": "Sale",
"amount": "$1,001 - $15,000",
"capitalGainsOver200USD": "False",
"comment": "",
"link": "https://disclosures-clerk.house.gov/public_disc/ptr-pdfs/2023/8220039.pdf"
},
{
"symbol": "INCY",
"senateID": "K000389",
"disclosureDate": "2023-10-06",
"transactionDate": "2023-09-06",
"firstName": "Ro",
"lastName": "Khanna",
"office": "Ro Khanna",
"district": "CA17",
"owner": "Spouse",
"assetDescription": "Incyte Corp",
"assetType": "Stock",
"type": "Sale",
"amount": "$1,001 - $15,000",
"capitalGainsOver200USD": "False",
"comment": "",
"link": "https://disclosures-clerk.house.gov/public_disc/ptr-pdfs/2023/8219992.pdf"
},
{
"symbol": "INCY",
"senateID": "K000389",
"disclosureDate": "2023-07-11",
"transactionDate": "2023-06-26",
"firstName": "Ro",
"lastName": "Khanna",
"office": "Ro Khanna",
"district": "CA17",
"owner": "",
"assetDescription": "Incyte Corp",
"assetType": "Stock",
"type": "Purchase",
"amount": "$1,001 - $15,000",
"capitalGainsOver200USD": "False",
"comment": "",
"link": "https://disclosures-clerk.house.gov/public_disc/ptr-pdfs/2023/8219826.pdf"
},
{
"symbol": "INCY",
"senateID": "K000389",
"disclosureDate": "2023-07-11",
"transactionDate": "2023-06-29",
"firstName": "Ro",
"lastName": "Khanna",
"office": "Ro Khanna",
"district": "CA17",
"owner": "Spouse",
"assetDescription": "Incyte Corp",
"assetType": "Stock",
"type": "Purchase",
"amount": "$1,001 - $15,000",
"capitalGainsOver200USD": "False",
"comment": "",
"link": "https://disclosures-clerk.house.gov/public_disc/ptr-pdfs/2023/8219826.pdf"
},
{
"symbol": "INCY",
"senateID": "K000389",
"disclosureDate": "2023-06-12",
"transactionDate": "2023-05-19",
"firstName": "Ro",
"lastName": "Khanna",
"office": "Ro Khanna",
"district": "CA17",
"owner": "Spouse",
"assetDescription": "Incyte Corp",
"assetType": "Stock",
"type": "Purchase",
"amount": "$1,001 - $15,000",
"capitalGainsOver200USD": "False",
"comment": "",
"link": "https://disclosures-clerk.house.gov/public_disc/ptr-pdfs/2023/8219783.pdf"
},
{
"symbol": "INCY",
"senateID": "G000599",
"disclosureDate": "2023-04-17",
"transactionDate": "2023-03-06",
"firstName": "Daniel",
"lastName": "Goldman",
"office": "Daniel Goldman",
"district": "NY10",
"owner": "",
"assetDescription": "Incyte Corporation",
"assetType": "Stock",
"type": "Sale (Full)",
"amount": "$1,001 - $15,000",
"capitalGainsOver200USD": "False",
"comment": "",
"link": "https://disclosures-clerk.house.gov/public_disc/ptr-pdfs/2023/20022653.pdf"
},
{
"symbol": "INCY",
"senateID": "K000389",
"disclosureDate": "2023-04-07",
"transactionDate": "2023-03-14",
"firstName": "Ro",
"lastName": "Khanna",
"office": "Ro Khanna",
"district": "CA17",
"owner": "Spouse",
"assetDescription": "Incyte Corp",
"assetType": "Stock",
"type": "Sale",
"amount": "$1,001 - $15,000",
"capitalGainsOver200USD": "False",
"comment": "",
"link": "https://disclosures-clerk.house.gov/public_disc/ptr-pdfs/2023/8219444.pdf"
},
{
"symbol": "INCY",
"senateID": "K000389",
"disclosureDate": "2023-02-07",
"transactionDate": "2023-01-09",
"firstName": "Ro",
"lastName": "Khanna",
"office": "Ro Khanna",
"district": "CA17",
"owner": "Spouse",
"assetDescription": "Incyte Corp",
"assetType": "Stock",
"type": "Purchase",
"amount": "$1,001 - $15,000",
"capitalGainsOver200USD": "False",
"comment": "",
"link": "https://disclosures-clerk.house.gov/public_disc/ptr-pdfs/2023/8219353.pdf"
},
{
"symbol": "INCY",
"senateID": "K000389",
"disclosureDate": "2023-01-03",
"transactionDate": "2022-12-06",
"firstName": "Ro",
"lastName": "Khanna",
"office": "Ro Khanna",
"district": "CA17",
"owner": "Spouse",
"assetDescription": "Incyte Corp",
"assetType": "Stock",
"type": "Sale",
"amount": "$1,001 - $15,000",
"capitalGainsOver200USD": "False",
"comment": "",
"link": "https://disclosures-clerk.house.gov/public_disc/ptr-pdfs/2022/8219318.pdf"
},
{
"symbol": "INCY",
"senateID": "C001123",
"disclosureDate": "2021-01-11",
"transactionDate": "2020-12-22",
"firstName": "Gilbert",
"lastName": "Cisneros",
"office": "Gilbert Cisneros",
"district": "CA31",
"owner": "",
"assetDescription": "Incyte Corporation",
"assetType": "Stock",
"type": "Sale (Full)",
"amount": "$1,001 - $15,000",
"capitalGainsOver200USD": "False",
"comment": "",
"link": "https://disclosures-clerk.house.gov/public_disc/ptr-pdfs/2021/20017992.pdf"
},
{
"symbol": "INCY",
"senateID": "C001123",
"disclosureDate": "2020-10-14",
"transactionDate": "2020-09-16",
"firstName": "Gilbert",
"lastName": "Cisneros",
"office": "Gilbert Cisneros",
"district": "CA31",
"owner": "",
"assetDescription": "Incyte Corporation",
"assetType": "Stock",
"type": "Purchase",
"amount": "$1,001 - $15,000",
"capitalGainsOver200USD": "False",
"comment": "",
"link": "https://disclosures-clerk.house.gov/public_disc/ptr-pdfs/2020/20017505.pdf"
}
],
"dark_pool": [
{
"ticker": "INCY",
"executed_at": "2026-10-19T15:44:19.430000Z",
"size": 1000.0,
"price": 113.31,
"premium": 113310.0,
"volume": 1000.0,
"trade_code": " "
},
{
"ticker": "INCY",
"executed_at": "2026-10-19T15:36:09.429000Z",
"size": 500.0,
"price": 113.21,
"premium": 56605.0,
"volume": 500.0,
"trade_code": " "
},
{
"ticker": "INCY",
"executed_at": "2026-10-19T15:37:30.165000Z",
"size": 466.0,
"price": 113.21,
"premium": 52755.86,
"volume": 466.0,
"trade_code": " "
},
{
"ticker": "INCY",
"executed_at": "2026-10-19T15:45:37.538000Z",
"size": 290.0,
"price": 113.2,
"premium": 32828.0,
"volume": 290.0,
"trade_code": " "
},
{
"ticker": "INCY",
"executed_at": "2026-10-19T15:36:58.912000Z",
"size": 200.0,
"price": 113.36,
"premium": 22672.0,
"volume": 200.0,
"trade_code": " "
},
{
"ticker": "INCY",
"executed_at": "2026-10-19T15:35:41.034000Z",
"size": 200.0,
"price": 113.21,
"premium": 22642.0,
"volume": 200.0,
"trade_code": " "
},
{
"ticker": "INCY",
"executed_at": "2026-10-19T15:45:37.538000Z",
"size": 198.0,
"price": 113.2,
"premium": 22413.600000000002,
"volume": 198.0,
"trade_code": "F"
},
{
"ticker": "INCY",
"executed_at": "2026-10-19T15:36:50.545000Z",
"size": 164.0,
"price": 113.26,
"premium": 18574.64,
"volume": 164.0,
"trade_code": " "
}
],
"ats": {
"symbol": "INCY",
"date": "20261016",
"ats_volume": 0,
"total_volume": 540511,
"ats_ratio": 0.0,
"ats_pct": 0.0,
"signal": "Low",
"history": [
{
"date": "20261016",
"ats_ratio": 0.0
},
{
"date": "20261015",
"ats_ratio": 0.0
},
{
"date": "20261014",
"ats_ratio": 0.0
},
{
"date": "20261013",
"ats_ratio": 0.0
},
{
"date": "20261012",
"ats_ratio": 0.0
}
]
},
"polygon_dp": {
"ticker": "INCY",
"days": [
{
"date": "2026-10-19",
"close": 113.07,
"vwap": 113.27,
"volume": 333151,
"vwap_discount_pct": 0.18
},
{
"date": "2026-10-16",
"close": 113.07,
"vwap": 113.17,
"volume": 1580667,
"vwap_discount_pct": 0.09
},
{
"date": "2026-10-15",
"close": 113.27,
"vwap": 113.79,
"volume": 1940494,
"vwap_discount_pct": 0.46
},
{
"date": "2026-10-14",
"close": 111.57,
"vwap": 111.31,
"volume": 1870089,
"vwap_discount_pct": -0.23
},
{
"date": "2026-10-13",
"close": 108.62,
"vwap": 108.63,
"volume": 2589566,
"vwap_discount_pct": 0.01
}
],
"avg_vwap_discount_pct": 0.1,
"signal": "Neutral"
},
"options_flow": [],
"net_premium": {
"ticker": "INCY",
"net_call_premium": "-2699.00",
"net_put_premium": "2608.00",
"call_premium": "23949.00",
"put_premium": "9273.00",
"bullish_premium": "9725.00",
"bearish_premium": "15032.00",
"put_call_ratio": "0.2083333333333333333333333333",
"iv_rank": "50.9786",
"implied_move_perc": "0.092",
"gex_ratio": null,
"gex_net_change": null,
"gex_call": "11885.3719",
"gex_put": "-24595.0539",
"gex_net": -12709.682,
"gex_call_delta": "338301.8250",
"gex_put_delta": "-535579.6995",
"gex_date": "2026-10-19"
},
"hot_chains": [
{
"underlying_symbol": "INCY",
"expires": "2026-12-18",
"open_interest": 576,
"option_type": "call",
"delta": 0.262863455460305,
"ask_volume": 5,
"last_price": "3.06",
"implied_volatility": "0.451428613969833",
"gamma": 0.01513134211925207,
"avg_price": "3.0969230769230769230769230769",
"bid_volume": 8,
"nbbo_ask": "3.60",
"strike": "130",
"option_symbol": "INCY261218C00130000",
"total_premium": "4026.00",
"iv": 0.469194520938802,
"volume": 13,
"nbbo_bid": "2.75"
},
{
"underlying_symbol": "INCY",
"expires": "2027-03-19",
"open_interest": 55,
"option_type": "call",
"delta": 0.232443501653867,
"ask_volume": 2,
"last_price": "3.41",
"implied_volatility": "0.3713038808360603",
"gamma": 0.0108344052339319,
"avg_price": "3.3840000000000000000000000000",
"bid_volume": 8,
"nbbo_ask": "4.60",
"strike": "140",
"option_symbol": "INCY270319C00140000",
"total_premium": "3384.00",
"iv": 0.387253124339667,
"volume": 10,
"nbbo_bid": "2.40"
},
{
"underlying_symbol": "INCY",
"expires": "2027-01-15",
"open_interest": 136,
"option_type": "call",
"delta": 0.1222014359567646,
"ask_volume": 8,
"last_price": "1.29",
"implied_volatility": "0.4333337232808737",
"gamma": 0.00809127773539332,
"avg_price": "1.3379999999999999999999999999",
"bid_volume": 2,
"nbbo_ask": "2.35",
"strike": "150",
"option_symbol": "INCY270115C00150000",
"total_premium": "1338.00",
"iv": 0.450287163235366,
"volume": 10,
"nbbo_bid": "0.20"
},
{
"underlying_symbol": "INCY",
"expires": "2026-12-18",
"open_interest": 512,
"option_type": "call",
"delta": 0.33801407697994,
"ask_volume": 0,
"last_price": "4.90",
"implied_volatility": "0.464135517965034",
"gamma": 0.016662336633665,
"avg_price": "4.90",
"bid_volume": 0,
"nbbo_ask": "6.20",
"strike": "125",
"option_symbol": "INCY261218C00125000",
"total_premium": "3920.00",
"iv": 0.47753675626082,
"volume": 8,
"nbbo_bid": "3.60"
},
{
"underlying_symbol": "INCY",
"expires": "2026-12-18",
"open_interest": 121,
"option_type": "call",
"delta": 0.1380682729342769,
"ask_volume": 0,
"last_price": "1.65",
"implied_volatility": "0.498655628800012",
"gamma": 0.00936604523973518,
"avg_price": "1.65",
"bid_volume": 8,
"nbbo_ask": "3.10",
"strike": "145",
"option_symbol": "INCY261218C00145000",
"total_premium": "1320.00",
"iv": 0.512352789044614,
"volume": 8,
"nbbo_bid": "0.35"
},
{
"underlying_symbol": "INCY",
"expires": "2026-11-20",
"open_interest": 291,
"option_type": "call",
"delta": 0.1708087647207625,
"ask_volume": 4,
"last_price": "1.65",
"implied_volatility": "0.473279576110916",
"gamma": 0.01644273997103926,
"avg_price": "1.6183333333333333333333333334",
"bid_volume": 2,
"nbbo_ask": "2.00",
"strike": "130",
"option_symbol": "INCY261120C00130000",
"total_premium": "971.00",
"iv": 0.459339590553068,
"volume": 6,
"nbbo_bid": "1.15"
},
{
"underlying_symbol": "INCY",
"expires": "2026-11-20",
"open_interest": 603,
"option_type": "put",
"delta": -0.391609418513794,
"ask_volume": 1,
"last_price": "4.45",
"implied_volatility": "0.459760187083551",
"gamma": 0.0252345423705736,
"avg_price": "4.3300",
"bid_volume": 0,
"nbbo_ask": "5.20",
"strike": "110",
"option_symbol": "INCY261120P00110000",
"total_premium": "2165.00",
"iv": 0.452953072311426,
"volume": 5,
"nbbo_bid": "2.90"
},
{
"underlying_symbol": "INCY",
"expires": "2026-11-20",
"open_interest": 368,
"option_type": "put",
"delta": -0.268486617087104,
"ask_volume": 0,
"last_price": "2.65",
"implied_volatility": "0.467566031592387",
"gamma": 0.02150707604938334,
"avg_price": "2.8000",
"bid_volume": 4,
"nbbo_ask": "3.00",
"strike": "105",
"option_symbol": "INCY261120P00105000",
"total_premium": "1400.00",
"iv": 0.456175895058726,
"volume": 5,
"nbbo_bid": "2.30"
}
],
"gamma_profile": {
"ticker": "INCY",
"spot": 113.02,
"date": "2026-10-19",
"flip_point": 80.06,
"net_gex": -12709.68,
"call_walls": [
{
"strike": 120.0,
"gex": 3248.13
},
{
"strike": 130.0,
"gex": 1941.15
},
{
"strike": 125.0,
"gex": 1838.83
}
],
"put_walls": [
{
"strike": 110.0,
"gex": -8508.35
},
{
"strike": 95.0,
"gex": -5997.53
},
{
"strike": 120.0,
"gex": -4267.04
}
],
"by_strike": [
{
"strike": 77.5,
"call_gex": 6.35,
"put_gex": -19.92,
"net_gex": -13.57
},
{
"strike": 80.0,
"call_gex": 64.77,
"put_gex": -22.73,
"net_gex": 42.04
},
{
"strike": 82.5,
"call_gex": 24.02,
"put_gex": -466.65,
"net_gex": -442.63
},
{
"strike": 85.0,
"call_gex": 56.71,
"put_gex": -69.67,
"net_gex": -12.96
},
{
"strike": 87.5,
"call_gex": 12.53,
"put_gex": -10.44,
"net_gex": 2.09
},
{
"strike": 90.0,
"call_gex": 98.99,
"put_gex": -95.04,
"net_gex": 3.95
},
{
"strike": 92.5,
"call_gex": 7.92,
"put_gex": -42.72,
"net_gex": -34.8
},
{
"strike": 95.0,
"call_gex": 33.08,
"put_gex": -5997.53,
"net_gex": -5964.45
},
{
"strike": 97.5,
"call_gex": 36.88,
"put_gex": -248.21,
"net_gex": -211.33
},
{
"strike": 100.0,
"call_gex": 235.97,
"put_gex": -1466.08,
"net_gex": -1230.12
},
{
"strike": 105.0,
"call_gex": 599.94,
"put_gex": -1482.41,
"net_gex": -882.47
},
{
"strike": 110.0,
"call_gex": 348.77,
"put_gex": -8508.35,
"net_gex": -8159.58
},
{
"strike": 115.0,
"call_gex": 1184.8,
"put_gex": -718.21,
"net_gex": 466.59
},
{
"strike": 120.0,
"call_gex": 3248.13,
"put_gex": -4267.04,
"net_gex": -1018.91
},
{
"strike": 125.0,
"call_gex": 1838.83,
"put_gex": -1088.91,
"net_gex": 749.92
},
{
"strike": 130.0,
"call_gex": 1941.15,
"put_gex": -20.96,
"net_gex": 1920.2
},
{
"strike": 135.0,
"call_gex": 536.92,
"put_gex": -5.2,
"net_gex": 531.72
},
{
"strike": 140.0,
"call_gex": 344.73,
"put_gex": 0.0,
"net_gex": 344.73
},
{
"strike": 145.0,
"call_gex": 245.99,
"put_gex": -0.97,
"net_gex": 245.02
},
{
"strike": 150.0,
"call_gex": 277.0,
"put_gex": -1.76,
"net_gex": 275.24
},
{
"strike": 155.0,
"call_gex": 139.19,
"put_gex": 0.0,
"net_gex": 139.19
},
{
"strike": 160.0,
"call_gex": 208.59,
"put_gex": 0.0,
"net_gex": 208.59
},
{
"strike": 165.0,
"call_gex": 266.95,
"put_gex": 0.0,
"net_gex": 266.95
},
{
"strike": 170.0,
"call_gex": 8.29,
"put_gex": 0.0,
"net_gex": 8.29
},
{
"strike": 175.0,
"call_gex": 50.32,
"put_gex": 0.0,
"net_gex": 50.32
}
]
},
"oi_changes": {
"net_call_oi_change": -2,
"net_put_oi_change": 379,
"top": [
{
"strike": "120",
"oi_change": 300,
"type": "put"
},
{
"strike": "110",
"oi_change": 79,
"type": "put"
},
{
"strike": "120",
"oi_change": -2,
"type": "call"
},
{
"strike": "95",
"oi_change": 0,
"type": "put"
},
{
"strike": "110",
"oi_change": 0,
"type": "put"
}
]
},
"opds": {
"opds": -1.0,
"D": -3.9,
"P": -3.0,
"O": -10.8,
"C": 26.7,
"signal": "NEUTRAL",
"direction": "bearish",
"coverage": 0.7,
"ranked": true,
"components": {
"M": 20.2,
"T": -41.9,
"RS": 4.0,
"V": -2.2,
"F": -21.4,
"OI": -100.0,
"S": 78.1,
"IV": null,
"B": null,
"Liquidity": 0.0,
"OpeningConfidence": null,
"FlowAgreement": 66.7,
"StrikeBreadth": null
},
"drivers": [
"- open-interest change -100",
"+ skew +78",
"- trend -42",
"- aggressive flow -21",
"+ momentum +20"
]
}
}
Data:
{
"vix": 16.87,
"sp500": 7718.94,
"fed_funds": 3.63,
"yield_curve_10y2y": 0.37,
"hy_spread": 3.16,
"treasury": {
"date": "2026-10-16",
"month1": 4.12,
"month2": 4.17,
"month3": 4.26,
"month6": 4.34,
"year1": 4.46,
"year2": 4.74,
"year3": 4.82,
"year5": 4.89,
"year7": 4.98,
"year10": 5.09,
"year20": 5.47,
"year30": 5.43
},
"events": []
}
Data:
{
"days": 103,
"patterns": [
{
"name": "VWAP Touch",
"count": 103,
"pct": 100
},
{
"name": "9 EMA Touch",
"count": 103,
"pct": 100
},
{
"name": "21 EMA Touch",
"count": 103,
"pct": 100
},
{
"name": "Woodie Pivot Touch",
"count": 100,
"pct": 97
},
{
"name": "ORB Breakout",
"count": 98,
"pct": 95
},
{
"name": "PDH/PDL Touch",
"count": 91,
"pct": 88
},
{
"name": "Open Retracement",
"count": 72,
"pct": 70
},
{
"name": "Gap Fill",
"count": 71,
"pct": 69
},
{
"name": "Darvas Box",
"count": 47,
"pct": 46
},
{
"name": "High Vol Open",
"count": 27,
"pct": 26
},
{
"name": "Power Hour",
"count": 13,
"pct": 13
}
]
}